Model Number MC1AVR1 |
Device Problems
Mechanical Problem (1384); Positioning Problem (3009); Appropriate Term/Code Not Available (3191); High Capture Threshold (3266)
|
Patient Problem
Tricuspid Valve Insufficiency/ Regurgitation (4453)
|
Event Date 08/22/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Other relevant device(s) are: d1: micra, d4: model #: mc1av r1-delsys, expiration date: 2024-09-14, serial#: (b)(6), udi #: (b)(4), d9: yes, return date: 2023-09-18, h3: no, device evaluation anticipated, but not yet begun, dev rtn to mfr? yes, h4: mfg date: 2023-03-15, h5: yes.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
It was reported that during implant of the leadless implantable pulse generator (ipg), when the first leadless implantable pulse generator (ipg) was attempted to be placed, the deflection of the delivery system was different than usual and it felt soft.It was also reported that there were occasions where it was difficult to recapture the leadless ipg with the delivery system.The leadless ipg was retrieved successfully using the delivery system with tether fully intact.It was further noted that the first leadless ipg had exhibited high thresholds.A second leadless ipg with no threshold issues seen.It was also noted that echocardiogram significant tricuspid regurgitation and that symptom was related to the procedure implant.No further patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
Product id: mc1avr1 product event summary: the device was returned and analyzed.Returned product analysis was performed and no anomalies were found.Product id: mc1avr1-delsys h3: yes product event summary: the delivery system was returned with the device intact in the device cup, analyzed.Analysis indicated the lumen of the delivery system was torn.The articulation curve of the delivery system did not meet specification.There was a deployment issue with the delivery system.The delivery system tether was frayed.The delivery system inner shaft was mechanically kinked/bent.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
A070102 removed as incorrectly added to this product medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|